Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICI) are effective in fractions of patients with disseminated melanoma. Significant toxicity can also occur from the treatments, that, in addition, are expensive. It is therefore important to increase the knowledge of predictive factors and their efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa Svedman, Fernanda, Jalsenius, Marie, Höiom, Veronica, Grozman, Vitali, Bergqvist, Mattias, Söderdahl, Fabian, Eriksson, Hanna, Rotstein, Samuel, Ny, Lars, Ascierto, Paolo A., Brage, Suzanne Egyhazi, Helgadottir, Hildur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833501/
https://www.ncbi.nlm.nih.gov/pubmed/35158970
http://dx.doi.org/10.3390/cancers14030702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833501/
https://www.ncbi.nlm.nih.gov/pubmed/35158970
http://dx.doi.org/10.3390/cancers14030702

Ejemplares similares